Skip to main content
SpringerLink
Log in

Antineoplastic drugs

Tumour lysis syndrome and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Benitez-Escobar EN, et al. First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma. Chinese Clinical Oncology 12: No. 4, 31 Aug 2023. Available from: URL: http://doi.org/10.21037/cco-22-111

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastic drugs. Reactions Weekly 1975, 38 (2023). https://doi.org/10.1007/s40278-023-46393-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-46393-2

Search

Navigation